authors
- Goss, G
- Hirte, Holger
- Batist, G
- Miller, W
- Stewart, D
- Matthews, S
- Seymour, L
NCIC CTG IND.122: a phase I/II pharmacokinetics (PK) and pharmacodynamic (PD) study of zd1839 (iressa ‘TM’). Final phase I results and preliminary phase II results of ZD1839 (750 mg/day) in patients (pts) with colorectal cancer
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2001
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- 1117 Public Health and Health Services (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- European Journal of Cancer Journal